attended last year
at London 2017
From London 2017
Dr. Niels Schaft
Dr Marc Cartellieri
Career
present
Chief Scientific Officer at Cellex Patient Treatment GmbH
2013 - 2014
Post-Doc., Institute of Radiopharmaceutical Cancer Research Dep. Radioimmunology, Helmholtz Zentrum Dresden Rossendorf, Germany
2005 - 2013
Post-Doc., Institute of Immunology, TU Dresden, Germany
Education
2000 - 2005
Doctoral Thesis (PhD): “Untersuchungen zum Gag- und Pol-Protein des Prototypischen Foamyvirus (PFV)“, Institute of Virology, TU Dresden, Germany
1993 - 2000
Master of Science (Biology), Ernst-Moritz-Arndt-Universität Greifswald, Germany
Gareth Thomas
Dr Stephen Miller
Dr. Stephen Miller is the Judy E. Gugenheim Research Professor of Microbiology-Immunology at Northwestern University Feinberg School of Medicine in Chicago. He received his Ph.D. in 1975 from the Pennsylvania State University and did postdoctoral training at the University of Colorado Health Sciences Center before joining the faculty at Northwestern in 1981 where he currently serves as Director of the Northwestern University Interdepartmental Immunobiology Center. Dr. Miller is internationally recognized for his research on pathogenesis and regulation of autoimmune diseases. He has published over 360 journal articles, reviews and book chapters and has trained multiple generations of scientists. His work has significantly enhanced understanding of immune inflammatory processes underlying chronic autoimmune disease employing animal models of multiple sclerosis (MS) and Type 1 diabetes (T1D). His work has focused on the study of the cellular and molecular mechanisms underlying treatment of established T cell-mediated autoimmune diseases using antigen-specific immune tolerance. His current work is is geared to translating the use of antigen-linked biodegradable PLG nanoparticles for the treatment of human immune-mediated diseases including autoimmunity, allergy and tissue/organ transplantation.
